Compound semiconductor developer and maker BluGlass has announced the close of its share purchase plan (SPP), which raised $5.3 million before costs.
The company said in a statement on Tuesday that the raise will accelerate production and delivery related to new and existing contracts, as well as support additional fab equipment and working capital. It follows a share placement, which attracted $2.3 million in support and was announced as complete at the beginning of May
BluGlass’s focus is on visible gallium nitride laser diode products for industrial, defence, bio-medical, scientific and other industries. It described its pipeline of orders as “robust” – with 26 active projects “in various stages of negotiation,” and collectively valued at $US 90-100 million.
“… [D]iscussions and negotiations continue to progress as we work with key industry partners to design-in BluGlass lasers in next-generation quantum, aerospace, and defence applications,” said CEO Jim Haden.
Picture: credit BluGlass
Editor’s note: BluGlass Chair James Walker will appear alongside Calix CEO and Managing Director Phil Hodgson and MicroBioGen’s CEO Geoff Bell at @AuManufacturing’s Spotlight on Scaling up event on June 25 at UTS. Their panel is titled “Patient capital: how long tech takes at times”. You can find ticketing and other information here.
Further reading
BluGlass receives first order from Indian Ministry of Defence